A Phase 2 clinical trial is currently recruiting adults with relapsing types of multiple sclerosis (MS) to investigate Zenas Biopharma’s experimental therapy obexelimab as a weekly subcutaneous ...
After hours: February 7 at 5:50:38 PM EST ...
After hours: February 7 at 4:03:37 PM EST Loading Chart for GLUE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback